Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
3.00
Dollar change
+0.02
Percentage change
0.67
%
Index- P/E- EPS (ttm)-2.86 Insider Own38.70% Shs Outstand19.40M Perf Week-2.91%
Market Cap89.22M Forward P/E- EPS next Y-3.05 Insider Trans-4.68% Shs Float18.23M Perf Month-84.46%
Income-59.68M PEG- EPS next Q-0.74 Inst Own54.89% Short Float1.84% Perf Quarter-81.63%
Sales0.00M P/S- EPS this Y-6.67% Inst Trans0.77% Short Ratio1.02 Perf Half Y-79.30%
Book/sh4.67 P/B0.64 EPS next Y-2.49% ROA-45.24% Short Interest0.34M Perf Year-73.68%
Cash/sh4.16 P/C0.72 EPS next 5Y- ROE-48.81% 52W Range2.93 - 22.22 Perf YTD-85.36%
Dividend Est.- P/FCF- EPS past 5Y- ROI-42.94% 52W High-86.50% Beta-0.26
Dividend TTM- Quick Ratio8.52 Sales past 5Y0.00% Gross Margin- 52W Low2.39% ATR (14)1.01
Dividend Ex-Date- Current Ratio8.52 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)13.79 Volatility7.58% 9.66%
Employees35 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom2.60 Target Price7.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-11.48% Payout- Rel Volume0.88 Prev Close2.98
Sales Surprise- EPS Surprise-0.39% Sales Q/Q- EarningsNov 09 AMC Avg Volume329.52K Price3.00
SMA20-67.96% SMA50-80.96% SMA200-76.87% Trades Volume289,870 Change0.67%
Date Action Analyst Rating Change Price Target Change
Feb-13-24Downgrade Leerink Partners Outperform → Market Perform $23 → $7
Feb-12-24Downgrade Oppenheimer Outperform → Perform
Feb-12-24Downgrade JMP Securities Mkt Outperform → Mkt Perform
Feb-12-24Downgrade Evercore ISI Outperform → In-line $25 → $7
Jan-04-24Initiated JMP Securities Mkt Outperform $30
Jul-18-22Resumed Oppenheimer Outperform $22
Feb-22-24 04:21AM
Feb-12-24 10:03AM
07:04AM
06:54AM
06:45AM
04:10PM Loading…
Jan-30-24 04:10PM
Jan-12-24 03:02AM
Jan-10-24 08:50AM
Nov-09-23 04:05PM
Nov-06-23 08:50AM
07:00AM
Oct-18-23 07:00AM
Oct-11-23 12:01AM
Sep-27-23 09:40AM
Sep-26-23 07:00AM
07:00AM Loading…
Sep-13-23 07:00AM
Sep-11-23 09:40AM
Aug-15-23 10:42PM
Aug-10-23 04:10PM
Jun-14-23 08:55AM
May-25-23 04:10PM
May-18-23 07:00AM
May-11-23 04:10PM
May-09-23 06:05AM
May-01-23 07:00AM
Mar-29-23 04:01PM
Feb-28-23 04:10PM
Jan-31-23 04:10PM
Dec-04-22 08:40AM
Nov-09-22 04:05PM
04:10PM Loading…
Nov-02-22 04:10PM
Oct-19-22 08:00AM
Oct-06-22 07:00AM
Sep-29-22 07:00AM
Aug-29-22 07:00AM
Aug-11-22 04:10PM
Aug-08-22 11:42AM
Jul-01-22 10:39AM
Jun-29-22 07:00AM
Jun-27-22 09:19AM
May-10-22 04:10PM
May-09-22 07:00AM
Apr-18-22 09:30AM
Mar-28-22 10:33AM
Mar-25-22 04:40PM
03:06PM
Mar-24-22 10:32PM
02:11PM
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zakrzewski Joseph SDirectorJan 18Sale19.11100,0001,911,410405,880Jan 19 07:32 PM
Aziz KabeerDirectorJan 16Sale19.65100,0001,965,000377,542Jan 18 06:19 PM
Adjuvant Global Health Technol10% OwnerJan 16Sale19.6584,0931,652,4271,995,958Jan 18 06:18 PM
Adjuvant Global Health Technol10% OwnerJan 16Sale19.6515,907312,573377,542Jan 18 06:18 PM
Readnour Robin ShaneDirectorJan 12Sale21.911,42531,229414,788Jan 17 05:03 PM
Readnour Robin ShaneDirectorJan 10Sale21.933,66980,443415,494Jan 12 05:08 PM
Krause Kevin MichaelChief Strategy OfficerJan 09Option Exercise4.597,41734,0159,331Jan 11 07:59 PM
Krause Kevin MichaelChief Strategy OfficerJan 09Sale20.147,417149,3671,914Jan 11 07:59 PM
Krause Kevin MichaelChief Strategy OfficerJan 02Option Exercise0.422,5831,0854,497Jan 04 06:06 PM
Easom EricChief Executive OfficerJan 02Sale20.092,77755,8022,130Jan 04 06:05 PM
Krause Kevin MichaelChief Strategy OfficerJan 02Sale20.122,58351,9671,914Jan 04 06:06 PM
Aziz KabeerDirectorNov 14Sale16.151,81029,224393,449Nov 16 06:57 PM
Adjuvant Global Health Technol10% OwnerNov 14Sale16.151,52224,5742,080,051Nov 16 06:59 PM
Adjuvant Global Health Technol10% OwnerNov 14Sale16.152884,650393,449Nov 16 06:59 PM
Aziz KabeerDirectorOct 02Sale16.075,67291,149393,737Oct 03 07:21 PM
Adjuvant Global Health Technol10% OwnerOct 02Sale16.074,77076,6542,081,573Oct 03 07:13 PM
Adjuvant Global Health Technol10% OwnerOct 02Sale16.0790214,495393,737Oct 03 07:13 PM
Aziz KabeerDirectorSep 29Sale16.2899,1011,613,364394,639Oct 03 07:21 PM
Adjuvant Global Health Technol10% OwnerSep 29Sale16.2883,3371,356,7262,086,343Oct 03 07:13 PM
Adjuvant Global Health Technol10% OwnerSep 29Sale16.2815,764256,638394,639Oct 03 07:13 PM
Aziz KabeerDirectorSep 28Sale16.118,516137,193410,403Sep 29 05:40 PM
Adjuvant Global Health Technol10% OwnerSep 28Sale16.117,160115,3482,169,680Sep 29 05:41 PM
Adjuvant Global Health Technol10% OwnerSep 28Sale16.111,35621,845410,403Sep 29 05:41 PM
Aziz KabeerDirectorSep 27Sale16.0784113,515411,759Sep 29 05:40 PM
Adjuvant Global Health Technol10% OwnerSep 27Sale16.0770711,3612,176,840Sep 29 05:41 PM
Adjuvant Global Health Technol10% OwnerSep 27Sale16.071342,153411,759Sep 29 05:41 PM
Aziz KabeerDirectorSep 13Sale16.004006,400411,893Sep 15 05:40 PM
Adjuvant Global Health Technol10% OwnerSep 13Sale16.003365,3762,177,547Sep 15 05:17 PM
Adjuvant Global Health Technol10% OwnerSep 13Sale16.00641,024411,893Sep 15 05:17 PM
Aziz KabeerDirectorSep 07Sale16.053,37854,217411,957Sep 08 04:57 PM
Adjuvant Global Health Technol10% OwnerSep 07Sale16.052,84145,5982,177,883Sep 08 04:59 PM
Adjuvant Global Health Technol10% OwnerSep 07Sale16.055378,619411,957Sep 08 04:59 PM
Aziz KabeerDirectorSep 06Sale16.023,76260,267412,494Sep 08 04:57 PM
Adjuvant Global Health Technol10% OwnerSep 06Sale16.023,16450,6872,180,724Sep 08 04:59 PM
Adjuvant Global Health Technol10% OwnerSep 06Sale16.025989,580412,494Sep 08 04:59 PM
Aziz KabeerDirectorAug 23Sale16.004006,400413,092Aug 25 04:30 PM
Adjuvant Global Health Technol10% OwnerAug 23Sale16.003365,3762,183,888Aug 25 04:31 PM
Adjuvant Global Health Technol10% OwnerAug 23Sale16.00641,024413,092Aug 25 04:31 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerAug 18Buy9.001,777,77816,000,0025,135,683Aug 22 05:01 PM
Easom EricChief Executive OfficerMay 15Buy5.3810,00053,7701,015,766May 15 08:01 PM